- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Hikal Ltd (HIKA)
Hikal Ltd stock price live, this page displays NSE HIKA stock exchange data. View the HIKA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Hikal Ltd real time stock price chart below.
What Is the Hikal Ltd Stock Price Today?
The Hikal Ltd stock price today is 260.05.
What Is the Stock Symbol for Hikal Ltd?
The stock symbol for Hikal Ltd is ""HIKA.""
What Stock Exchange Does Hikal Ltd Trade On?
Hikal Ltd is listed and trades on the NSE stock exchange.
Is Hikal Ltd a Good Stock to Buy?
Determining whether Hikal Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HIKA quote. (ISIN: INE475B01022)
What Is the Hikal Ltd Stock Price Today?
The Hikal Ltd stock price today is 260.05.
What Is the Stock Symbol for Hikal Ltd?
The stock symbol for Hikal Ltd is ""HIKA.""
What Stock Exchange Does Hikal Ltd Trade On?
Hikal Ltd is listed and trades on the NSE stock exchange.
Is Hikal Ltd a Good Stock to Buy?
Determining whether Hikal Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HIKA quote. (ISIN: INE475B01022)
260.05
-2.70(-1.03%)
Closed·
Fair Value
An estimate of a Hikal Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
259.00
262.75
52 wk Range
245.30
464.50
HIKA Scorecard
Full Analysis
Trading at a high earnings multiple
HIKA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Hikal Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
259.00262.75
52 wk Range
245.30464.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.54%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.54%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
HIKA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Hikal Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
390.00
Upside
+49.97%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Pharmaceuticals industry
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Hikal Ltd Company Profile
Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, biotechnology, life sciences, animal health, crop protection, and specialty chemicals indusries. It operates through two segments, Pharmaceuticals and Crop Protection. The company also manufactures pesticides and herbicides, which include diuron tech, temephos tech, thiacloprid tech, clothianidin tech, dichloroaniline, N-bromosuccinimide, prothioconazole technical, trifloxystrobin technical, and BIT. In addition, it offers solutions in contract research, custom synthesis, and custom manufacturing of intermediates and active ingredients. Further, the company provides anti-convulsant, anti-inflammatory, analgesic, Anti-parasitic, anti-lipemic, anti-histaminic, anti-depressant, anti-psychotic, anti-emetic, anti-diabetic, anti-thrombotic, Anti-viral, anti-hypertensive, and Haemorheologic; animal health products, such as anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone, insecticide, and NSAID; and specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company also exports its products. It operates in India, the United States, Canada, Europe, South East Asia, and internationally. The company was formerly known as Hikal Chemical Industries Ltd. and changed its name to Hikal Limited in April 2000. Hikal Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.
Compare HIKA to Peers and Sector
Metrics to compare | HIKA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHIKAPeersSector | |
|---|---|---|---|---|
P/E Ratio | 51.2x | 26.9x | −0.6x | |
PEG Ratio | −8.34 | 0.07 | 0.00 | |
Price/Book | 2.6x | 4.1x | 2.6x | |
Price / LTM Sales | 1.8x | 3.5x | 3.4x | |
Upside (Analyst Target) | 48.4% | 11.9% | 36.7% | |
Fair Value Upside | Unlock | 15.0% | 3.9% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 390.00
(+49.97% Upside)
Earnings
Latest Release
Aug 07, 2025
EPS / Forecast
-1.80 / --
Revenue / Forecast
3.71B / 2.79B
People Also Watch
FAQ
What Stock Exchange Does Hikal Ltd Trade On?
Hikal Ltd is listed and trades on the Bombay Stock Exchange stock exchange.
What Is the Stock Symbol for Hikal Ltd?
The stock symbol for Hikal Ltd is "HIKA."
What Is the Hikal Ltd Market Cap?
As of today, Hikal Ltd market cap is 32.06B.
What Is Hikal Ltd's Earnings Per Share (TTM)?
The Hikal Ltd EPS (TTM) is 5.14.
When Is the Next Hikal Ltd Earnings Date?
Hikal Ltd will release its next earnings report on 22 Oct 2025.
From a Technical Analysis Perspective, Is HIKA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Hikal Ltd Stock Split?
Hikal Ltd has split 4 times.
How Many Employees Does Hikal Ltd Have?
Hikal Ltd has 2062 employees.
What is the current trading status of Hikal Ltd (HIKA)?
As of 23 Sept 2025, Hikal Ltd (HIKA) is trading at a price of 260.05, with a previous close of 262.75. The stock has fluctuated within a day range of 259.00 to 262.75, while its 52-week range spans from 245.30 to 464.50.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.